. Phosphodiesterases as therapeutic targets for Huntington's disease. Curr Pharm Des. 2015;21(3):365-77. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. New PET Tracer Tracks Preclinical Movement Disorders